11.16.2021 - By The Lancet Group
Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.Read the full article:https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://yo...